Mitotic Kinases Aurora-A, Plk1, and Cdk1 Interact with Elk-1 Transcription Factor through the N-Terminal Domain.

Q3 Biochemistry, Genetics and Molecular Biology International Journal of Cell Biology Pub Date : 2024-04-30 eCollection Date: 2024-01-01 DOI:10.1155/2024/6798897
Oya Arı Uyar, Yigit Koray Babal, Bayram Yılmaz, Isil Aksan Kurnaz
{"title":"Mitotic Kinases Aurora-A, Plk1, and Cdk1 Interact with Elk-1 Transcription Factor through the N-Terminal Domain.","authors":"Oya Arı Uyar, Yigit Koray Babal, Bayram Yılmaz, Isil Aksan Kurnaz","doi":"10.1155/2024/6798897","DOIUrl":null,"url":null,"abstract":"<p><p>Elk-1 is a member of the ETS domain transcription factor superfamily that is phosphorylated upon mitogen-activated protein kinase (MAPK) pathway activation, which in turn regulated its interaction with partner protein serum response factor (SRF), leading to formation of a ternary complex with DNA. It has previously been reported that Elk-1 interacts with a mitotic kinase Aurora-A, although the mechanisms or the relevance of this interaction was unclear. Elk-1 was also reported to be phosphorylated by CDK5 on Thr417 residue. In this study, we show for the first time that this transcription factor interacts not only with Aurora-A but also with other mitotic kinases Aurora-B, Plk1, and Cdk1, and we define the interaction domain on Elk-1 to the first N-terminal 205 amino acids. We also describe putative phosphorylation sites of these mitotic kinases on Elk-1 and show that Elk-1 peptides containing these residues get phosphorylated by the mitotic kinases in <i>in vitro</i> kinase assays. We also perform bioinformatic analysis of mitotic phosphoproteomes and determine potential interaction partners for Elk-1 in Plk or Aurora phosphoproteomes. We propose that understanding the dynamic phosphorylation of Elk-1 by mitotic kinases is important and that it can present a novel target for anticancer strategies.</p>","PeriodicalId":39084,"journal":{"name":"International Journal of Cell Biology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11074830/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cell Biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2024/6798897","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

Elk-1 is a member of the ETS domain transcription factor superfamily that is phosphorylated upon mitogen-activated protein kinase (MAPK) pathway activation, which in turn regulated its interaction with partner protein serum response factor (SRF), leading to formation of a ternary complex with DNA. It has previously been reported that Elk-1 interacts with a mitotic kinase Aurora-A, although the mechanisms or the relevance of this interaction was unclear. Elk-1 was also reported to be phosphorylated by CDK5 on Thr417 residue. In this study, we show for the first time that this transcription factor interacts not only with Aurora-A but also with other mitotic kinases Aurora-B, Plk1, and Cdk1, and we define the interaction domain on Elk-1 to the first N-terminal 205 amino acids. We also describe putative phosphorylation sites of these mitotic kinases on Elk-1 and show that Elk-1 peptides containing these residues get phosphorylated by the mitotic kinases in in vitro kinase assays. We also perform bioinformatic analysis of mitotic phosphoproteomes and determine potential interaction partners for Elk-1 in Plk or Aurora phosphoproteomes. We propose that understanding the dynamic phosphorylation of Elk-1 by mitotic kinases is important and that it can present a novel target for anticancer strategies.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
有丝分裂激酶 Aurora-A、Plk1 和 Cdk1 通过 N 端域与 Elk-1 转录因子相互作用
Elk-1是ETS结构域转录因子超家族的成员,在丝裂原活化蛋白激酶(MAPK)通路激活时会被磷酸化,进而调节其与伙伴蛋白血清反应因子(SRF)的相互作用,导致与DNA形成三元复合物。以前曾有报道称,Elk-1 与有丝分裂激酶 Aurora-A 相互作用,但这种作用的机制或相关性尚不清楚。也有报道称 Elk-1 被 CDK5 磷酸化在 Thr417 残基上。在本研究中,我们首次发现该转录因子不仅能与 Aurora-A 相互作用,还能与其他有丝分裂激酶 Aurora-B、Plk1 和 Cdk1 相互作用。我们还描述了这些有丝分裂激酶在 Elk-1 上的推定磷酸化位点,并在体外激酶试验中表明,含有这些残基的 Elk-1 多肽会被有丝分裂激酶磷酸化。我们还对有丝分裂磷酸化蛋白组进行了生物信息学分析,确定了 Elk-1 在 Plk 或 Aurora 磷酸化蛋白组中的潜在相互作用伙伴。我们认为,了解有丝分裂激酶对 Elk-1 的动态磷酸化非常重要,它可以为抗癌策略提供一个新的靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
International Journal of Cell Biology
International Journal of Cell Biology Biochemistry, Genetics and Molecular Biology-Cell Biology
CiteScore
3.30
自引率
0.00%
发文量
4
审稿时长
20 weeks
期刊最新文献
The Role of Bcl-2 Family Proteins and Sorafenib Resistance in Hepatocellular Carcinoma. Mitotic Kinases Aurora-A, Plk1, and Cdk1 Interact with Elk-1 Transcription Factor through the N-Terminal Domain. Acute Genetic Damage Induced by Ethanol and Corticosterone Seems to Modulate Hippocampal Astrocyte Signaling. A Short Post-Reattachment Ultrasensitive Window of Time in Human Cancer Cells as Therapeutic Target of Prolonged Low-Dose Administration of Specific Compounds. RuX: A Novel, Flexible, and Sensitive Mifepristone-Induced Transcriptional Regulation System.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1